Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Annals of Internal Medicine

• Publication date

  1987-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.7326/0003-4819-107-4-513PMID 3498419
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sulindac-associated small bowel lesion.

  1986cited by this paper
• Nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding. A case-control study.

  1986cited by this paper
• Eicosanoids and the gastrointestinal tract: promising but no verdict yet.

  1986cited by this paper
• Ulcerations of the colon associated with naproxen and acetylsalicylic acid treatment.

  1986cited by this paper
• Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage.

  1985cited by this paper
• Are prostaglandins cytoprotective in the human large intestine?—the effect of indomethacin on rectal mucosal function and prostaglandin E2 releasein vivo

  1984cited by this paper
• Colitis associated with non-steroidal anti-inflammatory drugs.

  1984cited by this paper
• Prostaglandins and ulcerative colitis.

  1984cited by this paper
• Intestinal perforation associated with osmotic slow release indomethacin capsules.

  1983cited by this paper
• Prostanoids cytoprotection for maintaining remission in ulcerative colitis failure of 15(R), 15-methylprostaglandin E2

  1983cited by this paper
• Analgesic ingestion and other factors preceding relapse in ulcerative colitis.

  1983cited by this paper
• Benoxaprofen in the treatment of active ulcerative colitis.

  1983cited by this paper
• Enteritis and colitis associated with mefenamic acid.

  1983cited by this paper
• Enteritis and colitis associated with mefenamic acid

  1983cited by this paper
• Experimental colitis studied by colonoscopy in the rat: effect of indomethacin.

  1983cited by this paper
• Acute blinding sinusitis

  1983cited by this paper
• Microscopic colitis-a cause of chronic watery diarrhoea.

  1982cited by this paper
• Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity.

  1982cited by this paper
• Lower gastrointestinal side effects of nonsteroidal antiinflammatory drugs.

  1981cited by this paper
• Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs.

  1981cited by this paper
• Studies of prostaglandins and sulphasalazine in ulcerative colitis.

  1981cited by this paper
• Gastrin and intestinal phase of gastric secretion.

  1980cited by this paper
• Ulcerative enterocolitis in dogs induced by drugs

  1980cited by this paper
• Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.

  1980cited by this paper
• Prostaglandins, indomethacin, and ulcerative colitis.

  1980cited by this paper
• Prostaglandins and ulcerative colitis.

  1979cited by this paper
• Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone.

  1979cited by this paper
• Smoking and ulcers: true, true, and related?

  1979cited by this paper
• Gastrointestinal involvement in rheumatoid arthritis: a biopsy study.

  1979cited by this paper
• A note on indomethacin suppositories in rheumatic conditions.

  1979cited by this paper
• Acute perforation of colonic diverticula associated with short-term indomethacin.

  1978cited by this paper
• The ubiquitous prostaglandins and their role in ulcerative colitis.

  1978cited by this paper
• Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.

  1978cited by this paper
• Indomethacin and naproxen suppositories in the treatment of rheumatoid arthritis.

  1978cited by this paper
• Indomethacin-induced intestinal inflammation

  1977cited by this paper
• [Granulomatous colitis following naproxene].

  1976cited by this paper
• Letter: Rectal bleeding and indomethacin suppositories.

  1975cited by this paper

• Does aspirin worsen Crohn’s disease outcomes? A multicenter propensity-matched cohort study

  2026cites this paper
• Flavonoides en la dieta, perspectivas en la regulación de la inflamación intestinal

  2025cites this paper
• Elevated risk of adverse effects from foodborne contaminants and drugs in inflammatory bowel disease: a review

  2024cites this paper
• Wheat peptides inhibit the activation of MAPK and NF-κB inflammatory pathways and maintain epithelial barrier integrity in NSAID-induced intestinal epithelial injury.

  2023cites this paper
• Management of Pelvic Pain in Patients with Crohn’s Disease—Current Overview

  2023cites this paper
• Evaluation of the effect of tramadol, paracetamol and metamizole on the severity of experimental colitis

  2023cites this paper
• Induction of leaky gut by repeated intramuscular injections of indomethacin to preweaning Holstein calves.

  2022cites this paper
• The Association Between Nonsteroidal Anti-Inflammatory Drug Use and Inflammatory Bowel Disease Exacerbations: A True Association or Residual Bias?

  2022cites this paper
• REVISTA MÉDICA CLINICA LAS CONDES

  2021cites this paper
• Inflammatory bowel disease–like conditions: medication-induced enteropathy

  2020cites this paper
• Nonsteroidal Anti-Inflammatory Drug-Gastropathy and Enteropathy

  2019cites this paper
• Redox modulatory protective effects of ω-3 fatty acids rich fish oil against experimental colitis

  2019cites this paper
• Manifestaciones extraintestinales de enfermedad inflamatoria intestinal

  2019cites this paper
• Other Surgeries in Patients with Inflammatory Bowel Disease.

  2019cites this paper
• Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study

  2019cites this paper
• Focus on current and future management possibilities in inflammatory bowel disease-related chronic pain

  2018cites this paper
• Effects of Non-Steroid Anti-Inflammatory Drugs on the Lower Gastrointestinal Tract.

  2018cites this paper
• INTRODUCING o LVANCOCIN * " ORAL VANCOCIN IS THE DRUG OF CHOICE FOR C DIFFICILE ENTEROCOLITIS . " l NEW VANCOON CAPSULES

  2018cites this paper
• Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis—An Evidence-based Consensus Guideline From the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition

  2018cites this paper
• Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases☆

  2017cites this paper
• Review article: a practical approach to the clinical management of NSAID enteropathy

  2017cites this paper
• Soluble epoxide hydrolase as a therapeutic target for pain , in fl ammatory and neurodegenerative diseases ☆

  2017cites this paper
• [Management of severe ulcerative colitis: An up-to-date].

  2017influential citation
• Disorders of the Gastrointestinal System

  2017cites this paper
• Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease

  2016cites this paper
• in acutely injured porcine ileum recovery restitution is the primary determinant of barrier PG-mediated closure of paracellular pathway and not

  2016cites this paper
• Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbation of Inflammatory Bowel Disease.

  2016cites this paper
• Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account

  2016cites this paper
• RECTOSIGMOID INFLAMMATORY LESIONS AND ITS DETERMINANTS IN PATIENTS WITH ANKYLOSING SPONDYLITIS

  2016cites this paper
• Microbiome, Metabolome and Inflammatory Bowel Disease

  2016cites this paper
• Flavonoids in Inflammatory Bowel Disease: A Review

  2016cites this paper
• Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease

  2015cites this paper
• Id1 expression in endothelial cells of the colon is required for normal response to injury.

  2015influential citation
• Extraintestinal Manifestations of Inflammatory Bowel Disease

  2015cites this paper
• Nonsteroidal anti-inflammatory drug-induced intestinal graft loss 12 years after transplantation.

  2015cites this paper
• Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.

  2015cites this paper
• Piroxicam Treatment Augments Bone Abnormalities in Interleukin-10 Knockout Mice

  2015cites this paper
• Review Histological evaluation in ulcerative colitis

  2014cites this paper
• Effet des cellules stromales mésenchymateuses (CSM) sur l'hypersensibilité viscérale chronique dans un modèle d'ulcération colique radio-induite chez le rat

  2014cites this paper
• Anti-TNF-α therapy for renal amyloid as a complication of Crohn's disease.

  2014influential citation
• Characterisation of enterocolitis in the piroxicam-accelerated interleukin-10 knock out mouse--a model mimicking inflammatory bowel disease.

  2014cites this paper
• Consensus guidelines for managing acute severe ulcerative colitis in children : a joint statement from ECCO , ESPGHAN , and the Pediatric IBD Porto Group Running title : Guidelines for managing acute severe colitis in children

  2014cites this paper
• The Colon

  2014influential citation
• Inflammatory bowel disease.

  2014cites this paper
• Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment.

  2014cites this paper
• Mesalamine treatment mimicking relapse in a child with ulcerative colitis

  2014cites this paper
• Histological evaluation in ulcerative colitis

  2014cites this paper
• Toxicité des AINS pour les patients MICI : mythe ou réalité ?

  2014cites this paper
• Nonsteroidal Anti-inflammatory Drugs and Inflammatory Bowel Disease: Pathophysiology and Clinical Associations

  2014cites this paper
• Dietary supplementation of arachidonic acid increases arachidonic acid and lipoxin A4 contents in colon, but does not affect severity or prostaglandin E2 content in murine colitis model

  2014cites this paper
• Therapeutics for the treatment of spondyloarthritis: what, when and whom

  2013cites this paper
• Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability.

  2013cites this paper
• E-type prostanoid receptor 4 (EP4) in disease and therapy

  2013cites this paper
• Enteropathic Spondyloarthritis: From Diagnosis to Treatment

  2013cites this paper
• Tight Junctions and the Intestinal Barrier

  2012cites this paper
• Soluble Epoxide Hydrolase Gene Deficiency or Inhibition Attenuates Chronic Active Inflammatory Bowel Disease in IL-10(−/−) Mice

  2012cites this paper
• Inflammatory Disorders of the Large Intestine

  2012cites this paper
• Clinical reviews in allergy and immunology

  2012cites this paper
• Consensus for Managing Acute Severe Ulcerative Colitis in Children: A Systematic Review and Joint Statement From ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN

  2011cites this paper
• Inflammatory Bowel Disease

  2011influential citation
• Managing pain in inflammatory bowel disease.

  2011cites this paper
• Rheumatological manifestations in inflammatory bowel disease

  2011cites this paper
• An herbal therapeutic approach to food intolerance and immune dysfunction: An illustrative case history

  2011cites this paper
• Chemoprevention of Chronic Inflammatory Bowel Disease-Induced Carcinogenesis in Rodent Models by Berries

  2011cites this paper
• Clinical Dilemmas in Inflammatory Bowel Disease

  2011cites this paper
• Myosin Light Chain Kinase Pathways in a Mouse Model of Endotoxinemia Berberine Ameliorates Intestinal Epithelial Tight-Junction Damage and Down-regulates

  2011cites this paper
• Current therapeutics for spondyloarthritis

  2011cites this paper
• Immunomodulatory Effects of Lactobacillus casei Administration in a Mouse Model of Gliadin‐Sensitive Enteropathy

  2011cites this paper
• Ankylosing spondylitis or Crohn's disease? Case report and review of the literature.

  2010cites this paper
• Non‐Steroidal Anti‐Inflammatory Drug‐Induced Gastro‐Duodenal Toxicity

  2010cites this paper
• Drug-induced Injury of the Gastrointestinal Tract.

  2010cites this paper
• Persistent enteric mycobacterial infection sensitizes mice to intestinal epithelial injury

  2010cites this paper
• [Multifactorial etiology and pathogenic factors in inflammatory bowel disease].

  2009cites this paper
• Do NSAIDs, Antibiotics, Infections, or Stress Trigger Flares in IBD?

  2009cites this paper
• Rheumatic manifestations of inflammatory bowel disease.

  2009cites this paper
• Miscellaneous diseases of the small intestine

  2009cites this paper
• Disorders of the Gastrointestinal System

  2009cites this paper
• Intestinal barrier function: molecular regulation and disease pathogenesis.

  2009cites this paper
• Etiología multifactorial y parcelas patogénicas de la enfermedad inflamatoria intestinal

  2009cites this paper
• Cyclooxygenase-2 in mucosal DC mediates induction of regulatory T cells in the intestine through suppression of IL-4

  2009cites this paper
• Prostaglandin-mediated closure of paracellular pathway and not restitution is the primary determinant of barrier recovery in acutely injured porcine ileum

  2008cites this paper
• Evidence‐based recommendations for the monitoring and treatment of ankylosing spondylitis: results from the Australian 3E initiative in rheumatology

  2008cites this paper
• Low-dose aspirin-induced gastrointestinal diseases: past, present, and future

  2008cites this paper
• Maintenance of Medically Induced Remission of Crohn’s Disease

  2008cites this paper
• 5-Lipoxygenase-derived lipid mediators are not required for the development of NSAID-induced inflammatory bowel disease in IL-10-/- mice.

  2008cites this paper
• New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets.

  2008cites this paper
• Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: a pilot study comparing seal oil and cod liver oil.

  2008cites this paper
• [Nutritional management of inflammatory bowel disease].

  2008cites this paper
• Indications and Challenges of Probiotics, Prebiotics, and Synbiotics in the Management of Arthralgias and Spondyloarthropathies in Inflammatory Bowel Disease

  2008cites this paper
• Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists.

  2008cites this paper
• An update on pediatric gastroenterology and nutrition: a review of some recent advances.

  2008cites this paper
• Drug-induced injury in the gastrointestinal tract: clinical and pathologic considerations

  2007cites this paper
• An herbal medicine orengedokuto prevents indomethacin-induced enteropathy.

  2007cites this paper
• Non-steroidal Anti-inflammatory D Monitoring to help prevent serious adverse effiects

  2007cites this paper
• [Common errors in the management of outpatients with inflammatory bowel disease].

  2007cites this paper
• Carprofen compromises the integrity and barrier function of the colonic mucosa of the dog

  2007cites this paper
• Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts.

  2007cites this paper
• Healing Impairment Effect of Cyclooxygenase Inhibitors on Dextran Sulfate Sodium-Induced Colitis in Rats

  2007cites this paper
• Traitement par boue et eau thermales dans la spondylarthrite associée à une entérocolopathie inflammatoire : essai clinique pilote randomisé

  2007cites this paper
• Effect of Withdrawal of Nonsteroidal Anti-Inflammatory Drug Use on Ileal Pouch Disorders

  2007cites this paper